Rumax International Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 16-11-2024
- Revenue 57.71%
(FY 2023)
- Profit 63.40%
(FY 2023)
- Ebitda 104.06%
(FY 2023)
- Net Worth 64.61%
(FY 2023)
- Total Assets 71.97%
(FY 2023)
About Rumax International
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Kanchan Gupta and Rajendra Gupta serve as directors at the Company.
- CIN/LLPIN
U51909DL2017PTC312612
- Company No.
312612
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rumax International Private Limited offer?
Rumax International Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Camera & Photography Equipments, Camera Lenses, Eye Diagnosis & Surgery Instruments, Eye Testing Machines, Sexual Wellness Products, Contraceptives, Optical, Laser Instruments & Devices, Medical Lasers.
Who are the key members and board of directors at Rumax International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanchan Gupta  | Director | 09-Feb-2017 | Current |
| Rajendra Gupta | Director | 09-Feb-2017 | Current |
Financial Performance of Rumax International.
Rumax International Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.71% increase. The company also saw a substantial improvement in profitability, with a 63.4% increase in profit. The company's net worth Soared by an impressive increase of 64.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rumax International?
In 2023, Rumax International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Matronix Optotechnik Private LimitedActive 4 years 2 monthsKanchan Gupta and Rajendra Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 31 May 2022 | ₹2.00 Cr | Open |
How Many Employees Work at Rumax International?
Unlock and access historical data on people associated with Rumax International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rumax International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rumax International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
